Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RGEN

Repligen Corp.

Sep 10 • 04:00PM ET

146.70

Dollar change +2.21
Percentage change 1.53	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IJH VB VXF VBK MDY IBB IJK FBT VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.04	Insider Own	7.02%	Shs Outstand	55.77M	Perf Week	3.46%
Market Cap	8.22B	Forward P/E	76.96	EPS next Y	1.91	Insider Trans	-1.18%	Shs Float	52.07M	Perf Month	-11.18%
Income	-1.90M	PEG	-	EPS next Q	0.34	Inst Own	100.81%	Short Float	8.45%	Perf Quarter	3.87%
Sales	602.35M	P/S	13.64	EPS this Y	-17.76%	Inst Trans	1.47%	Short Ratio	4.71	Perf Half Y	-24.04%
Book/sh	35.53	P/B	4.13	EPS next Y	32.43%	ROA	-0.07%	Short Interest	4.40M	Perf Year	-9.12%
Cash/sh	14.45	P/C	10.15	EPS next 5Y	14.71%	ROE	-0.10%	52W Range	110.45 - 211.13	Perf YTD	-18.41%
Dividend Est.	-	P/FCF	68.90	EPS past 5Y	15.08%	ROI	-0.07%	52W High	-30.52%	Beta	0.95
Dividend TTM	-	Quick Ratio	5.56	Sales past 5Y	31.42%	Gross Margin	42.18%	52W Low	32.82%	ATR (14)	6.45
Dividend Ex-Date	-	Current Ratio	6.65	EPS Y/Y TTM	-101.36%	Oper. Margin	2.51%	RSI (14)	48.15	Volatility	3.25% 4.39%
Employees	1783	Debt/Eq	0.37	Sales Y/Y TTM	-17.41%	Profit Margin	-0.32%	Recom	1.40	Target Price	192.25
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	-83.34%	Payout	0.00%	Rel Volume	0.58	Prev Close	144.49
Sales Surprise	-0.03%	EPS Surprise	1.20%	Sales Q/Q	-3.20%	Earnings	Jul 30 BMO	Avg Volume	934.87K	Price	146.70
SMA20	-2.63%	SMA50	2.46%	SMA200	-11.34%	Trades		Volume	537,773	Change	1.53%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151
May-07-20	Reiterated	H.C. Wainwright	Buy	$100 → $143
Mar-23-20	Reiterated	H.C. Wainwright	Buy	$110 → $100
Nov-15-19	Initiated	Stifel	Buy
Nov-01-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$107 → $110
Oct-15-19	Initiated	SVB Leerink	Outperform	$100
Aug-28-19	Reiterated	First Analysis Sec	Outperform	$95 → $107

Show Previous Ratings

Sep-09-24 05:20AM	Reasons for the Decline of Repligen (RGEN) in Q2 (Insider Monkey)
Sep-07-24 07:37AM	Repligen Corporation (RGEN) Fell Due to CEO Transition (Insider Monkey)
Aug-29-24 11:31AM	Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-23-24 08:43AM	Repligen Corporation (RGEN) Benefitted From Drug Approval (Insider Monkey)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
04:39AM	Loading…
Aug-16-24 04:39AM	Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? (Insider Monkey) -9.26%
Aug-02-24 07:09AM	Here's Why Shares in This Hot Healthcare Stock Surged This Week (Motley Fool)
Jul-31-24 10:46AM	Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates (Zacks)
12:30AM	Q2 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 08:45AM	Repligen (RGEN) Q2 Earnings Meet Estimates (Zacks) +16.37%
07:45AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:55AM	Should You Consider Investing in Repligen Corporation (RGEN)? (Insider Monkey)
Jul-29-24 04:00PM	Repligen Announces Agreement to Acquire Chromatography Innovator Tantti (GlobeNewswire)
Jul-23-24 10:01AM	Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:21AM	Loading…
Jul-20-24 08:21AM	Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now? (Insider Monkey)
Jul-16-24 07:30AM	Repligen to Report Second Quarter 2024 Financial Results (GlobeNewswire) +10.11%
Jun-24-24 07:33AM	Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock? (Zacks)
Jun-15-24 02:50AM	Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN) (GuruFocus.com)
02:50AM	Director Nicolas Barthelemy Acquires 1,200 Shares of Repligen Corp (RGEN) (GuruFocus.com)
Jun-14-24 11:43AM	Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change (Zacks)
Jun-13-24 07:00AM	Repligen Announces CEO Transition Plan (GlobeNewswire) -11.85%
Jun-03-24 08:00AM	Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing (Business Wire)
May-31-24 11:31AM	Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-23-24 02:12AM	Insider Sell: CEO Anthony Hunt Sells 20,072 Shares of Repligen Corp (RGEN) (GuruFocus.com)
May-22-24 07:30AM	Repligen Corporation to Present at Upcoming June Investor Conferences (GlobeNewswire)
May-15-24 09:53AM	Here's Why Baron Discovery Fund Sold Repligen Corporation (RGEN) (Insider Monkey)
May-07-24 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-24 11:31AM	UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating (MT Newswires) +5.02%
11:31AM	Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:23AM	Loading…
11:23AM	Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates (Zacks)
03:06AM	Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ... (GuruFocus.com)
May-01-24 11:53AM	RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:11AM	Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections (GuruFocus.com)
08:50AM	Repligen (RGEN) Misses Q1 Earnings Estimates (Zacks)
08:47AM	Repligen's Q1 Adjusted Earnings, Revenue Fall (MT Newswires)
07:47AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-23-24 11:43AM	Should be Confident in Repligen Corporation (RGEN)'s Long-Term Growth Potential? (Insider Monkey) +8.76%
Apr-17-24 07:30AM	Repligen to Report First Quarter 2024 Financial Results (GlobeNewswire)
Apr-12-24 10:07AM	Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation (Insider Monkey)
09:49AM	Should You Sell Pool Corporation (POOL)? (Insider Monkey)
Mar-19-24 07:30AM	Repligen Appoints Maggie A. Pax to Board of Directors (GlobeNewswire)
Mar-12-24 01:18AM	Repligen Corp CEO Anthony Hunt Sells 16,707 Shares (GuruFocus.com)
Feb-27-24 02:02AM	Repligen Corp COO James Bylund Sells 4,373 Shares (GuruFocus.com)
Feb-24-24 12:03AM	Decoding Repligen Corp (RGEN): A Strategic SWOT Insight (GuruFocus.com)
Feb-22-24 11:24AM	Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:39AM	Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y (Zacks)
Feb-21-24 08:45AM	Repligen (RGEN) Lags Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income (GuruFocus.com)
07:51AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-07-24 07:30AM	Repligen to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-31-24 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-29-24 05:09AM	Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength? (Zacks)
Dec-19-23 07:30AM	Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 04:49AM	Here's Why Repligen Corporation (RGEN) Rose 13% in Q3 (Insider Monkey)
Dec-07-23 07:30AM	Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements (GlobeNewswire)
Nov-30-23 11:31AM	Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-15-23 07:15AM	Does Repligen Corp. (RGEN) Have a Bright Future? (Insider Monkey)
Nov-14-23 02:01PM	UPDATE Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire) +5.55%
07:30AM	Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire)
Nov-07-23 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 07:30AM	Repligen Launches TangenX SC as First-to-Market Holder-Free Self-Contained TFF Device (GlobeNewswire)
Nov-01-23 12:10PM	Repligen Corporation (NASDAQ:RGEN) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:46AM	Repligen (RGEN) Shares Rise on Q3 Earnings & Revenue Beat (Zacks)
12:04AM	Q3 2023 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-31-23 09:41AM	Repligen Corp (RGEN) Reports Q3 2023 Earnings: Revenue Down 30% Y/Y (GuruFocus.com) +17.86%
09:12AM	Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outlook (RTT News)
08:50AM	Repligen (RGEN) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:41AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-25-23 10:01AM	Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for (Zacks) -10.99%
Oct-24-23 10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-17-23 11:44AM	Repligen (RGEN)'s Hidden Value: An In-Depth Analysis of Its Market Worth (GuruFocus.com)
07:30AM	Repligen to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-02-23 07:30AM	Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer (GlobeNewswire)
Sep-27-23 06:51AM	Repligen (RGEN) to Acquire Fluid Management Company Metenova (Zacks)
Sep-26-23 12:41PM	Waltham's Repligen to acquire Swedish firm (American City Business Journals)
07:30AM	Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova (GlobeNewswire)
Sep-14-23 10:10AM	Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains? (Zacks)
Sep-12-23 07:30AM	Repligen Appoints Jason K. Garland as Chief Financial Officer (GlobeNewswire)
Sep-06-23 03:06AM	Reasons For the Decline of Repligen Corporation (RGEN) (Insider Monkey)
Sep-01-23 12:19PM	Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. (Barrons.com)
11:31AM	Why Is Repligen (RGEN) Up 2.9% Since Last Earnings Report? (Zacks)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-21-23 06:53AM	What Makes Repligen Corporation (RGEN) a Quality Investment? (Insider Monkey)
Aug-17-23 08:00AM	Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification (GlobeNewswire)
Aug-10-23 09:39AM	Multiple Headwinds Impacted Repligen Corp. (RGEN)s Performance in Q2 (Insider Monkey)
Aug-09-23 06:10AM	News Flash: 14 Analysts Think Repligen Corporation (NASDAQ:RGEN) Earnings Are Under Threat (Simply Wall St.)
Aug-03-23 11:19AM	Repligen (RGEN) Beats on Q2 Earnings, Lowers '23 Guidance (Zacks)
Aug-02-23 08:55AM	Repligen (RGEN) Q2 Earnings Surpass Estimates (Zacks)
07:49AM	Repligen: Q2 Earnings Snapshot (AP Finance)
07:30AM	Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
Jul-31-23 09:08AM	What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate? (Simply Wall St.)
Jul-26-23 10:02AM	Earnings Preview: Repligen (RGEN) Q2 Earnings Expected to Decline (Zacks)
Jul-25-23 11:40AM	EXEL or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Jul-20-23 10:01AM	Estee Lauder downgraded, AB InBev upgraded: Wall Street's top analyst calls (The Fly)
Jul-19-23 07:30AM	Repligen to Report Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-10-23 08:34AM	Are Options Traders Betting on a Big Move in Repligen (RGEN) Stock? (Zacks)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Option Exercise	86.10	175	15,067	12,463	Aug 05 09:56 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Sale	159.35	7,148	1,139,016	12,288	Aug 05 09:56 PM
Ralf Kuriyel	Senior Vice President	Aug 02 '24	Proposed Sale	159.35	7,148	1,139,040		Aug 02 03:26 PM
KURIYEL RALF	Senior VP, R&D	Aug 01 '24	Sale	165.67	4,465	739,717	19,261	Aug 01 08:47 PM
MUIR GLENN P	Director	Aug 01 '24	Option Exercise	36.29	5,000	181,450	13,283	Aug 01 05:04 PM
Christine Gebski	Senior Vice President	Aug 01 '24	Proposed Sale	167.00	2,160	360,720		Aug 01 04:11 PM
Ralf Kuriyel	Senior Vice President	Aug 01 '24	Proposed Sale	165.67	4,465	739,705		Aug 01 04:07 PM
Madaus Martin D	Director	Jun 14 '24	Buy	124.94	1,615	201,776	4,613	Jun 14 06:07 PM
BARTHELEMY NICOLAS	Director	Jun 14 '24	Buy	125.45	1,200	150,540	4,668	Jun 14 05:42 PM
Hunt Anthony	Chief Executive Officer	Jun 14 '24	Buy	124.08	2,000	248,160	165,177	Jun 14 05:41 PM
DAWES KAREN A	Director	Jun 14 '24	Option Exercise	67.71	2,953	199,948	88,170	Jun 14 05:33 PM
Hunt Anthony	Chief Executive Officer	May 21 '24	Sale	168.26	20,072	3,377,283	163,177	May 22 05:14 PM
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Option Exercise	86.10	1,271	109,433	27,777	Mar 12 08:24 PM
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Sale	193.73	3,517	681,348	24,260	Mar 12 08:24 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Option Exercise	16.55	1	17	201,956	Mar 11 07:43 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Sale	197.44	16,707	3,298,632	185,249	Mar 11 07:43 PM
DAWES KAREN A	Director	Feb 27 '24	Option Exercise	42.07	4,626	194,616	88,367	Feb 28 09:56 PM
DAWES KAREN A	Director	Feb 27 '24	Sale	193.35	1,000	193,350	87,367	Feb 28 09:56 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Option Exercise	94.33	940	88,670	18,508	Feb 26 08:38 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Sale	198.08	4,373	866,204	14,135	Feb 26 08:38 PM
Gebski Christine	See Remarks	Nov 10 '23	Sale	147.13	3,788	557,328	28,787	Nov 13 05:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RGEN

Repligen Corp.

Upgrade your FINVIZ experience